12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Dynavax completes equity-based line of credit

Dynavax Technologies Corp. (NASDAQ:DVAX), Berkeley, Calif.
Business: Inflammation, Infectious, Autoimmune
Date completed: 9/20/10
Type: Equity-based line of...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >